Heavy menstrual bleeding can cause iron-deficiency anemia (IDA), but having periods does not prove that menstruation is the only cause. The family medicine decision is whether a plausible uterine source makes an initial iron-and-follow-up plan reasonable—or whether the history calls for gastrointestinal evaluation now as well.
Treat menstrual loss as a hypothesis, not a verdict
Start by confirming that the patient has both anemia and iron deficiency; evidence about evaluating IDA does not automatically apply to an isolated low ferritin. Then take a menstrual history detailed enough to judge whether the reported loss could plausibly account for the anemia: how long and how often bleeding lasts, whether it involves flooding or frequent product changes, whether there are large clots, and how much it disrupts daily life. Ask about bleeding between periods and how the pattern has changed from the patient’s baseline.
A vague note that the patient “has heavy periods” is not a complete explanation. Menstrual loss, gastrointestinal blood loss, reduced absorption, diet, and blood donation can coexist. Ask about gastrointestinal bleeding, abdominal pain, bowel changes, unexplained weight loss, swallowing symptoms, family history of gastrointestinal cancer, and medicines such as NSAIDs that may contribute to bleeding. If uterine bleeding is abnormal, assess it on its own merits rather than assuming iron will solve the problem.
Why the endoscopy decision is conditional
Bidirectional endoscopy—upper endoscopy and colonoscopy—can identify gastrointestinal bleeding lesions or other causes of iron deficiency. But for an asymptomatic premenopausal patient, the balance is less straightforward than it is for a man or a postmenopausal woman without another clear source. The likelihood of a gastrointestinal lesion, the patient’s age and risk history, the possible harms of procedures, and the patient’s preferences all matter.
Guidance differs. A U.S. guideline conditionally suggests bidirectional endoscopy for asymptomatic premenopausal women rather than iron alone, while recognizing that a younger patient with a plausible non-GI cause may reasonably choose initial iron treatment after discussion. A major UK guideline generally takes a more selective approach to endoscopy in younger women, while recommending attention to celiac disease and additional clinical warning features. These are not contradictory claims that one test is always right: they reflect limited direct evidence and different judgments about how to balance a small chance of missed disease against the burdens of investigation.
If gastrointestinal symptoms are present, evaluate in a way that responds to those symptoms; a symptom-directed assessment may change which investigation comes first. A normal menstrual history should not delay evaluation of a concerning GI symptom, and a plausible menstrual source does not erase a strong family history or other risk signal.
Choose the next step from the whole pattern
| History pattern | How to think about it | Reasonable direction |
|---|---|---|
| GI bleeding, unexplained weight loss, persistent abdominal symptoms, a strong early-onset family history of GI cancer, or IDA that persists, worsens, recurs, or seems disproportionate to menstrual loss—or is newly recognized without a clear explanation | A menstrual source may coexist with a significant GI cause | Arrange prompt diagnostic evaluation; substantial active bleeding or hemodynamic instability requires emergency assessment. Tailor the first investigation to symptoms and coordinate the broader workup as needed. |
| Younger patient with a well-documented pattern of substantial menstrual loss, no GI symptoms or major risk features, and stable clinical status | Menstrual loss is plausible, but not proven to be the only cause | Discuss the options. An initial iron plan with gynecologic assessment and planned reassessment may be reasonable if the patient prefers to defer endoscopy after discussion. |
| Menstrual history is vague, the bleeding does not seem sufficient to explain the anemia, or the anemia persists or returns | The presumed source has not adequately explained the course | Revisit the history and lower the threshold for GI evaluation rather than continuing iron without a diagnostic plan. |
Celiac disease can cause iron deficiency even without prominent digestive symptoms. BSG guidance recommends celiac serologic screening in young women with IDA; AGA guidance suggests serologic testing when celiac disease is plausible. Include celiac disease in the evaluation rather than relying on digestive symptoms alone. Also keep screening and diagnosis separate: being up to date with routine colorectal cancer screening does not, by itself, answer whether a patient’s anemia needs diagnostic evaluation.
Iron response is not a source test
Iron replacement can improve hemoglobin whether the iron was lost through menstruation, the gastrointestinal tract, or both. Improvement shows that iron treatment is helping; it does not locate the source or prove that no second cause exists.
If an iron-first approach is chosen, make it an active plan: address the menstrual bleeding, start appropriate iron replacement, schedule reassessment of the anemia and iron status, and agree in advance what will prompt further evaluation. A poor response should lead to a review of adherence, tolerance, ongoing blood loss, and possible malabsorption—not just an automatic increase in iron. Recurrence after improvement also deserves a fresh search for the cause.
Common reasoning traps
- “She menstruates, so the cause is settled.” Menstruation is a possible source, not proof that other sources are absent.
- “Every menstruating patient needs immediate bidirectional endoscopy.” Recommendations for asymptomatic premenopausal patients are conditional and depend on risk, context, and preference.
- “The hemoglobin improved, so further evaluation is unnecessary.” Response to iron does not identify where the iron was lost.
- “No digestive symptoms means no GI cause.” Some causes of iron deficiency, including malabsorption, may not produce prominent symptoms.
Practical takeaways
- Confirm IDA, then document menstrual loss carefully rather than assuming it explains the anemia.
- Ask about GI symptoms, family risk, medication-related bleeding, and whether the anemia is persistent, worsening, recurrent, or disproportionate to reported menstrual loss.
- For a younger, asymptomatic patient with a credible menstrual source, shared decision-making about initial iron treatment versus endoscopy is appropriate; guidance is not uniform.
- Investigate concerning features promptly, and assess abnormal uterine bleeding in parallel when indicated.
- Treat iron response as a treatment result—not proof of the cause—and set a follow-up plan before choosing to defer endoscopy.
